Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lian Bizhi injection plus levofloxacin for adult community-acquired pneumonia
ChiCTR2000034912Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lian Bizhi in community-acquired pneumonia (CAP) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: VAS rating of cough, Sputum volume score and 11 more. Started Jul 2018; status: completed.
02
Drugs
Lian Bizhi
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2000034912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034912.